Nanocarriers As Pulmonary Drug Delivery

We have collected information about Nanocarriers As Pulmonary Drug Delivery for you. Follow the links to find out details on Nanocarriers As Pulmonary Drug Delivery.


Nanocarriers as pulmonary drug delivery systems to treat ...

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526354/
    Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases Malgorzata Smola , 1, 2 Thierry Vandamme , 1 and Adam Sokolowski 2 1 Université Louis Pasteur, Faculté de Pharmacie, Département de Chimie Bioorganique, Illkirch Graffenstaden, FranceAuthor: Malgorzata Smola, Thierry Vandamme, Adam Sokolowski

Albumin nanocarriers for pulmonary drug delivery: An ...

    https://www.sciencedirect.com/science/article/pii/S1773224719317137
    Pulmonary drug delivery is attempted for treatment of diseases like tuberculosis , cancer , bacterial infections [48,49]. When compared with intravenous route, delivery and action of hormones, insulin and other proteins by inhalation route is more efficacious . There are three possible mechanisms of particle transport in lung, impaction, sedimentation and diffusion.Author: Monica Joshi, Mangal Nagarsenkar, Bala Prabhakar

Pulmonary drug delivery: a review on nanocarriers for ...

    https://academic.oup.com/jac/article/70/11/2945/2363606
    Jul 22, 2015 · Drug delivery by means of DPIs is considered the most convenient, as it is free of propellant and is chemically stable and patient friendly. Usually, however, drug or nanocarriers have to undergo additional formulation steps in order to be suitable for DPI administration. 23Author: M. Moreno-Sastre, M. Moreno-Sastre, M. Pastor, M. Pastor, C. J. Salomon, C. J. Salomon, A. Esquisabe...

(PDF) Nanocarriers as pulmonary drug delivery systems to ...

    https://www.researchgate.net/publication/5362929_Nanocarriers_as_pulmonary_drug_delivery_systems_to_treat_and_to_diagnose_respiratory_and_non_respiratory_diseases
    Nanocarriers as pulmonary drug delivery systems Diffusional deposition occurs mostly when the particles have just entered the nasopharynx, and is also most likely to occur

Albumin nanocarriers for pulmonary drug delivery: An ...

    https://www.sciencedirect.com/science/article/abs/pii/S1773224719317137
    Albumin, abundantly present in human body, is a biocompatible and biodegradable polymer used in drug delivery systems. It is relatively an inexpensive polymer with several advantages like non-toxicity, high drug loading capacity, binding efficiency with many drugs which qualifies it as an ideal nanocarrier.Author: Monica Joshi, Mangal Nagarsenkar, Bala Prabhakar

Nanocarriers for Respiratory Diseases Treatment: Recent ...

    http://www.eurekaselect.com/121255/article
    Pulmonary delivery of locally-acting drugs encapsulated in nanocarriers provides several advantages for the treatment of respiratory diseases such as asthma, chronic obstructive pulmonary diseases, cystic fibrosis, tuberculosis and lung cancer.

Biodegradable polymeric nanocarriers for pulmonary drug ...

    https://www.researchgate.net/publication/5324598_Biodegradable_polymeric_nanocarriers_for_pulmonary_drug_delivery
    Pulmonary drug delivery is attractive for both local and systemic drug delivery as a non-invasive route that provides a large surface area, thin epithelial barrier, high blood flow and the ...

Red blood cell-hitchhiking boosts delivery of nanocarriers ...

    https://www.nature.com/articles/s41467-018-05079-7
    Jul 11, 2018 · Drug delivery by nanocarriers (NCs) has long been stymied by dominant liver uptake and limited target organ deposition, even when NCs are targeted using affinity moieties.Author: Jacob S. Brenner, Daniel C. Pan, Jacob W. Myerson, Oscar A. Marcos-Contreras, Carlos H. Villa, Priya...

Nanoparticle-Mediated Pulmonary Drug Delivery: A Review

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013600/
    Apr 08, 2014 · Pulmonary drug delivery is rapidly gaining importance, due to the multiple advantages. Lungs offer a vast variety of advantages over conventional oral drug delivery. The large surface area and the elimination of the first past effect makes the absorption of drugs in the lungs faster.Author: Mukta Paranjpe, Christel C. Müller-Goymann

Searching for Nanocarriers As Pulmonary Drug Delivery?

You can just click the links above. The data is collected for you.

Related Delivery Info